Changes in polymorphonuclear leukocyte surface and plasma bactericidal/permeability-increasing protein and plasma lipopolysaccharide binding protein during endotoxemia or sepsis

S. E. Calvano, W. A. Thompson, M. N. Marra, S. M. Coyle, H. F. de Riesthal, R. K. Trousdale, P. S. Barie, R. W. Scott, L. L. Moldawer and S. F. Lowry
Surgical Immunology Laboratory, New York Hospital, Cornell University Medical College, New York.

OBJECTIVE: To evaluate changes in levels of polymorphonuclear leukocyte surface bactericidal/permeability-increasing protein (BPI), plasma BPI, and plasma lipopolysaccharide (LPS) binding protein (LBP) in normal human volunteers administered Escherichia coli LPS and in patients with sepsis and gram-negative infections. DESIGN: Survey; case series. SETTING: Clinical research center and surgical intensive care unit of a medical school and an associated tertiary care hospital. PATIENTS OR OTHER PARTICIPANTS: Volunteers (n = 10) screened prior to study by history and physical examination to exclude those with underlying diseases or hematologic abnormalities. Consecutive sample of surgical intensive care unit patients (n = 10) meeting criteria for sepsis syndrome with gram-negative infection. An additional patient with systemic inflammatory response syndrome but no gram-negative infection. All patients were studied on meeting the criteria. Three of the patients with sepsis syndrome and the patient with systemic inflammatory response syndrome were evaluated on recovery (approximately 25 days after initial study). Because these studies in volunteers and patients overlapped temporally, the control values were those of volunteers evaluated prior to LPS administration. No matching was employed. MEASUREMENTS AND RESULTS: Compared with controls, LPS-challenged volunteers and patients with sepsis both exhibited significant granulocytosis (P < .01) and increased concentrations of polymorphonuclear leukocyte surface BPI (P < .01) and of plasma LBP (P < .01). Plasma BPI concentrations were increased (P < .01) in volunteers following LPS administration. There was a trend toward increased concentrations of plasma BPI in patients, but this was not significant relative to controls. Maximum concentrations of plasma LBP were approximately 250- and 3000-fold higher than plasma BPI concentrations in endotoxemic volunteers and in patients, respectively. CONCLUSIONS: Circulating polymorphonuclear leukocytes increase expression of BPI in response to LPS or gram-negative sepsis. Subsequently, concentrations of plasma BPI and LBP increase. Because both LBP and BPI bind to LPS, it is suggested that endogenously derived plasma levels of BPI are likely to be inadequate to compete for LPS binding to the much more abundant LBP in the circulation.

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Review: From therapy to experimental model: a hundred years of endotoxin administration to human subjects
Bahador and Cross
Innate Immunity 2007;13:251-279.
ABSTRACT  

Acute Inflammatory Response to Endotoxin in Mice and Humans
Copeland et al.
CVI 2005;12:60-67.
ABSTRACT | FULL TEXT  

Acute-Phase Concentrations of Lipopolysaccharide (LPS)-Binding Protein Inhibit Innate Immune Cell Activation by Different LPS Chemotypes via Different Mechanisms
Hamann et al.
Infect. Immun. 2005;73:193-200.
ABSTRACT | FULL TEXT  

Lipopolysaccharides in liver injury: molecular mechanisms of Kupffer cell activation
Su
Am. J. Physiol. Gastrointest. Liver Physiol. 2002;283:G256-G265.
ABSTRACT | FULL TEXT  

High concentrations of lipopolysaccharide-binding protein in serum of patients with severe sepsis or septic shock inhibit the lipopolysaccharide response in human monocytes
Zweigner et al.
Blood 2001;98:3800-3808.
ABSTRACT | FULL TEXT  

Changes in Endotoxin-Binding Proteins during Major Elective Surgery: Important Role for Soluble CD14 in Regulation of Biological Activity of Systemic Endotoxin
Hiki et al.
CVI 1999;6:844-850.
ABSTRACT | FULL TEXT  

Lipoproteins inhibit macrophage activation by lipoteichoic acid
Grunfeld et al.
J. Lipid Res. 1999;40:245-252.
ABSTRACT | FULL TEXT  

Mass Concentration of Plasma Phospholipid Transfer Protein in Normolipidemic, Type IIa Hyperlipidemic, Type IIb Hyperlipidemic, and Non–Insulin-Dependent Diabetic Subjects as Measured by a Specific ELISA
Desrumaux et al.
Arterioscler. Thromb. Vasc. Bio. 1999;19:266-275.
ABSTRACT | FULL TEXT  

p15s (15-kD Antimicrobial Proteins) Are Stored in the Secondary Granules of Rabbit Granulocytes: Implications for Antibacterial Synergy With the Bactericidal/Permeability-Increasing Protein in Inflammatory Fluids
Zarember et al.
Blood 1997;89:672-679.
ABSTRACT | FULL TEXT  

Plasma Lipopolysaccharide-binding Protein Is Found Associated with a Particle Containing Apolipoprotein A-I, Phospholipid, and Factor H-related Proteins
Park and Wright
J. Biol. Chem. 1996;271:18054-18060.
ABSTRACT | FULL TEXT  

Effects of bactericidal/permeability-increasing protein upon mononuclear cell interactions with endotoxin: evidence for cell binding
Burnett et al.
Innate Immunity 1995;2:349-357.
ABSTRACT